melanoma tissues; adjacent normal tissues; benign nevi; mouse subcutaneous xenografts
A-375; SK-MEL-2; HEMn; HUVECs
cell line-derived xenograft
proliferation (promotes); migration (promotes); invasion (promotes); angiogenesis (promotes); apoptosis (inhibits); metastasis (promotes); ceRNA regulation (other)
RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; CCK8; Colony Formation Assay; EdU Staining; Annexin V/PI Flow Cytometry; Transwell Assay; Tube Formation Assay; Western Blot; IHC (Immunohistochemistry); In Vivo Animal Model; Bioinformatics Analysis
CircRTTN expression was analyzed for correlation with clinicopathological parameters of patients with melanoma, but no prognosis or diagnostic value was reported in the provided text.
CircRTTN/hsa_circ_0108830 is an up-regulated human circRNA derived from RTTN in melanoma tissues and cell lines. It promotes melanoma malignant behaviors including proliferation, migration, invasion, angiogenesis and tumor growth, while suppressing apoptosis. Mechanistically, circRTTN sponges miR-890 to increase EPHA2 expression, forming a circRTTN/miR-890/EPHA2 regulatory axis.
0.8443
CircRTTN upregulates EPHA2 to aggravate the malignant process of melanoma via sponging miR-890.
combined biological and clinical study